Direct answer: The studies compared here do not establish whether oral or injected 5-Amino-1MQ works better in people. They do provide animal absorption measurements: a 2021 rat study reported 38.4% oral bioavailability, while a 2024 mouse study described poor oral bioavailability and substantial exposure after subcutaneous administration. These are different species and experiments, not a human head-to-head trial.
Oral versus injection: compare the actual experiments
| Study | Species and question | Administration routes | Reported finding | What it answers |
|---|---|---|---|---|
| Neelakantan et al., 2018 | Diet-induced obese mice; metabolic effects | Subcutaneous treatment over 11 days | Reduced body weight, white adipose mass and adipocyte size compared with saline; no change in total food intake | A preclinical treatment experiment, not an oral comparison |
| Awosemo et al., 2021 | Rats; analytical assay and pharmacokinetics | Intravenous and oral administration | Oral bioavailability 38.4%; oral maximum plasma concentration 2,252 ng/mL; reported terminal half-lives 3.80 hours IV and 6.90 hours oral | Measured absorption and exposure in rats, not a weight-loss trial |
| Babula et al., 2024 | Mice; pharmacokinetics and metabolic effects | IV, oral and subcutaneous routes in the PK experiments; separate 28-day treatment experiment | Figure 5 describes poor oral bioavailability and substantial exposure after subcutaneous dosing; treatment limited fat-mass gain and improved metabolic measures | Mouse route-specific exposure and treatment results, not a capsule-versus-injection trial in people |
Why the rat percentage and mouse finding can differ
The 38.4% number belongs to the rat experiment. It cannot be applied to a human capsule or substituted for a mouse measurement. Species, administered formulation and experimental design are part of the result. A statement that 5-Amino-1MQ always has either good or poor oral absorption loses that context.
The earlier article said no formal bioavailability measurement had been published for either species. The 2021 rat record directly contradicts that statement. The earlier FAQ also called oral dosing the default in all available research, although the 2018 study used subcutaneous dosing. The table above resolves those contradictions with study-specific records.
Absorption, exposure and effectiveness answer different questions
Bioavailability is the fraction of an administered amount reaching systemic circulation. Plasma exposure describes concentrations over time. Effectiveness concerns an outcome such as body weight or fat mass. The rat assay paper measured the first two; it did not establish a human weight-loss effect.
From the FormBlends catalog
5-Amino-1MQ
NNMT inhibitor studied for metabolic aging and fat loss in research models · From $89/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
Learn about 5-Amino-1MQ →In the 2024 paper, the plasma profiles in Figure 5 and the 28-day metabolic experiment are separate parts of the study. Combining them into a claim that a retail injection outperforms a capsule in people would require evidence those experiments do not provide.
How to read a route comparison
- Identify the species before interpreting an absorption percentage.
- Check whether the endpoint is plasma exposure, tissue distribution or a treatment outcome.
- Keep the study's route and formulation attached to its finding.
- Check whether compared doses are matched before treating a concentration difference as route superiority.
Frequently asked questions
Has oral 5-Amino-1MQ bioavailability been measured?
Yes, in animals. Awosemo and colleagues reported 38.4% in rats in 2021. That number is not a measured human bioavailability percentage.
Did the early weight-loss experiment use oral capsules?
No. Neelakantan and colleagues used subcutaneous treatment in diet-induced obese mice over 11 days.
Does higher plasma exposure prove better fat loss?
No. An exposure measurement and a treatment outcome are different endpoints. Neither establishes a human oral-versus-injection winner without the corresponding clinical comparison.
Is 5-Amino-1MQ a peptide?
The primary studies describe it as a small-molecule nicotinamide N-methyltransferase inhibitor. Its target is NNMT; it is not a peptide chain.
Sources checked
- 2018 NNMT inhibitor study in diet-induced obese mice
- 2021 rat assay, pharmacokinetics and oral bioavailability study
- 2024 mouse pharmacokinetics and metabolic study, including Figure 5
If a supplier cannot provide a third-party COA with identity confirmation, do not use the product. Appearance alone tells you nothing about purity or identity.
Safety Unknowns Worth Knowing Before Either Route
NNMT has context-dependent roles. It is overexpressed in several cancers including gastric adenocarcinoma, thyroid, and bladder tumors, and in those contexts NNMT inhibition has been proposed as a therapeutic strategy. However, NNMT also regulates methylation balance in non-adipose tissues. Sustained systemic inhibition across multiple tissues in a healthy adult is a pharmacological action whose long-term consequences have not been studied in humans.
The concern is not proven harm. It is proven ignorance. No 90-day human safety study, no liver function or methylation biomarker tracking study, and no drug interaction study has been published. Practitioners using this compound are operating entirely outside the safety envelope established by clinical pharmacology. That is not a reason to assume harm; it is a reason to be honest about what is unknown.
For injection specifically: anyone considering subcutaneous injection of a research chemical should understand that pharmaceutical-grade injectable preparation requires sterile manufacturing conditions that are not guaranteed in research chemical supply chains. The endotoxin risk is real, not theoretical.
Related peptide guides
Ready when you are
5-Amino-1MQ
NNMT inhibitor studied for metabolic aging and fat loss in research models · From $89/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
Learn about 5-Amino-1MQ →